MILITELLO JOHN enters IMMUNE PHARMACEUTICALS INC with 2K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 1/1/2016ACC: 0001144204-16-074085
Officer· See Remarks
Since Dec 2015
2K
Baseline shares
100% direct
2K
Direct ownership
1 position
75K
Derivative underlying
2 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned2K
Total
2K direct2K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 2K | Direct |
| Total | 2K | 2K direct |
Derivative Holdings2
Stock Option
DirectUnderlying security
Common Stock
Underlying shares
10K
Shares owned
N/A
Exercise price
1.84
Expiration
—
Exercise window
—
Stock Option
DirectUnderlying security
Common Stock
Underlying shares
65K
Shares owned
N/A
Exercise price
1.98
Expiration
—
Exercise window
—
Total
Underlying
75K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option Direct | Common Stock | 1.84 | — | — | 10K | N/A |
| Stock Option Direct | Common Stock | 1.98 | — | — | 65K | N/A |
| Total | 75K | 0.00 | ||||